What Advantages Does Each Central American Country Offer Spanish Pharmaceutical Companies?
Central America brings together markets with very different characteristics. Some stand out for their logistics infrastructure, others for their tax incentives or market size. As a result, pharmaceutical companies do not necessarily approach expansion in the region in the same way.
Understanding what each country offers helps companies decide where to establish operations, how to organize distribution, and which markets to enter first based on their business objectives.
Panama: A Starting Point for Regional Operations
Panama is often one of the first markets companies consider when evaluating expansion into Central America. In addition to using the US dollar as legal tender, the country has special regimes such as the Colón Free Zone and Panamá Pacífico, which offer incentives for certain activities.
Its location is another advantage. The Panama Canal, Tocumen International Airport, and the Colón Free Zone facilitate product distribution to other countries in Central America and the Caribbean. Panama also has infrastructure for handling products that require cold chain storage and transportation, including biologics and vaccines.
For companies looking to establish a regional base, Panama is often part of the discussion.
Costa Rica: A Well-Established Life Sciences Industry
Costa Rica combines incentives under its Free Trade Zone Regime with a life sciences industry that has developed over the past several decades. The country also has logistics infrastructure for exports and a healthcare system recognized throughout the region.
These conditions make Costa Rica an attractive market for many companies looking to establish operations in the pharmaceutical and medical device industries.
Guatemala: The Region’s Largest Market
With approximately 17 million inhabitants, Guatemala has the largest population in Central America.
In addition to its free trade zones and Puerto Quetzal, one of the country’s main foreign trade hubs, Guatemala has a local pharmaceutical industry with a significant presence in the generic medicines segment.
For companies looking to expand their regional presence, Guatemala’s market size often makes it a priority in their planning.
El Salvador: A Market That Can Complement a Regional Strategy
El Salvador uses the US dollar and offers free trade zones and incentives for export activities. The country also has the Port of Acajutla and infrastructure supporting the movement of goods throughout the region.
These characteristics can make El Salvador an attractive part of a regional strategy, particularly for companies looking to serve multiple markets in a coordinated manner.
Honduras: An Opportunity for Continued Growth
Honduras offers incentives for free trade zones and export activities. Puerto Cortés is also one of the main ports on Central America’s Caribbean coast, supporting maritime trade.
Depending on the product type and expansion plan, Honduras can be included in a strategy covering several countries in the region.
Each country offers different advantages. The most suitable strategy will depend on the company’s objectives and how regulatory, commercial, and logistical considerations are integrated.
Nicaragua: A Market to Evaluate Within a Regional Plan
Nicaragua has free trade zones, ports such as Corinto and El Rama, and mechanisms designed to facilitate certain foreign trade operations.
When evaluating this market, companies should consider the most suitable entry approach and how Nicaragua fits into their broader expansion plan.
Belize: A Market Often Included in Gradual Expansion
Belize offers benefits for certain import operations and has connections to the Caribbean through the Port of Belize City.
Given its market size, some companies include Belize as part of a regional strategy alongside other Central American countries.
How to Decide Where to Start
There is no single answer that applies to every company.
While some companies may benefit from establishing regional operations in Panama or Costa Rica, others may choose to start with Guatemala because of its market size or enter several countries simultaneously through distributors.
The decision will depend on the product type, commercial strategy, available resources, and each pharmaceutical company’s growth objectives.
Conclusion
Central America offers different opportunities for Spanish pharmaceutical companies, but each market brings something different. Some stand out for their logistics infrastructure, others for their incentives or market size.
Rather than searching for one “ideal” country, many companies achieve better results by evaluating how to combine the strengths of several markets within a single regional expansion strategy.